<DOC>
	<DOCNO>NCT01495377</DOCNO>
	<brief_summary>The purpose study determine weather remifentanil induce swallow difficulty increase risk pulmonary aspiration .</brief_summary>
	<brief_title>Opioid Induced Swallowing Difficulties Risk Pulmonary Aspiration</brief_title>
	<detailed_description>Remifentanil opioids widely use anesthetic sedation minor surgical procedure pain relief icu-patients patient spontaneously breathe airway secure endotracheal intubation . In circumstance inability clear pharynx swallow may increase risk aspiration.In previous study ( yet publish ) show remifentanil induce subjective swallowing difficulty healthy volunteer aim study determine weather remifentanil infusion healthy non-intubated volunteer increase risk pulmonary aspiration . To assess question go study 14 volunteer randomise receive remifentanil infusion target concentration 3 ng/ml 60 minute one occasion equal amount saline . Radioactive Technetium colloid solution parallelly infuse pliable catheter transnasally . After remifentanil infusion stop transnasal catheter remove volunteer ask swallow water clear remain radioactivity upper gastrointestinal tract . Thereafter lung scan gamma camera perform . Through mechanism remifentanil cause swallow difficulty known.To determine weather remifentanil induce general muscle weakness volunteer measurement grip strength use Jamar dynamometer perform , 15 minute remifentanil infusion .</detailed_description>
	<mesh_term>Deglutition Disorders</mesh_term>
	<mesh_term>Remifentanil</mesh_term>
	<criteria>18 40 year old healthy volunteer sex . Have sign date Informed Consent . Willing able comply protocol duration trial . Pharyngoesophageal dysfunction Anamnesis pharyngoesophageal dysfunction Known history cardiac , pulmonary neurological disease Ongoing medication Allergies history reaction naloxone , remifentanil , fentanyl analogue ingredient History reaction product contain human albumine Pregnancy breast feed BMI &gt; 30 Previous participation medical clinical trial opioid use last 30 day participate medicinal clinical trial trial followup complete</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>swallow difficulty</keyword>
	<keyword>remifentanil</keyword>
	<keyword>pulmonary aspiration</keyword>
	<keyword>scintigraphy</keyword>
</DOC>